If you haven't noticed the new HCPCS code changes for immune globulin injections yet, your carrier certainly has -- and will reject claims that use the now-deleted Q series codes. A new MLN Matters article, effective Jan. 1, alerts practices that CMS has extended intravenous immune globulin (IVIG) payment though 2008, but with a couple of changes. Chief among the changes is the news that the previous IVIG codes (Q4087, Q4088, Q4091 and Q4092) have been deleted. This code series went into effect last July, so some practices may still be cutting their teeth on these Q codes. But as Medicare has been known to do before, carriers will now deny these codes for dates of service on or after Jan. 1, 2008. "Immune globulin is now more specific by drug name," says Toscha S. Willis, CPC, in Charlotte, N.C. Instead, Willis says, you should use these codes,: • J1561 -- Gamunex, 500 mg, liquid Medicare will continue to reimburse you for G0332 (Services for intravenous infusion of immunoglobulin prior to administration [this service is to be billed in conjunction with administration of immunoglobulin]) to describe the physician's IVIG pre-administration. "You can bill this code in addition to the infusion and drug codes," says Tiffany Spencer, CPC, a senior coding and billing consultant from North Carolina. "It is for obtaining the IVIG because there is such a shortage. Medicare reimburses approximately $60-$70 for the code." Don't Forget Administration Code Your coding will be complete once you add the appropriate administration code. For the physician's work infusing these drugs, you should still report 90765 (Intravenous infusion, for therapy, prophylaxis or diagnosis; initial, up to one hour). Include add-on code +90766 (... each additional hour) if the infusion lasts more than one hour. Hidden trap: Example: Solution: The MLN Matters article also reminds you to bill only one IVIG pre-administration code "per patient per day of IVIG administration" and that carriers will deny claims as unprocessable if they don't include G0332 along with the drug's J code. This will impact physicians who practice in a facility-based setting (such as place of service 22, Outpatient hospital). A physician may only report G0332, the corresponding J code and 90765 when the service is performed in his private office setting (POS 11). When you provide patients with these services in an outpatient hospital setting, the facility reports both G0332 and the J code because the facility obtains and purchases the immune globulin on the physician's behalf. In a hospital setting, the physician can report only the appropriate administration codes (for example, 90765). To read the full text of the MLN Matters article, visit the CMS Web site at http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5713.pdf.
• J1562 -- Vivaglobin, 100 mg
• J1568 -- Octagam, 500 mg, liquid
• J1569 -- Gammagard, 500 mg, liquid
• J1572 -- Flebogamma, 500 mg, liquid
• J1566 was revised this year to indicate "not otherwise specified" IVIG or Carimune.